|
gptkbp:instanceOf
|
gptkb:brand
|
|
gptkbp:antidote
|
supportive care
activated charcoal
|
|
gptkbp:ATCCode
|
N05CA01
|
|
gptkbp:brand
|
gptkb:pentobarbital
|
|
gptkbp:CASNumber
|
76-74-4
|
|
gptkbp:contraindication
|
porphyria
severe respiratory disease
|
|
gptkbp:controlledSubstanceSchedule
|
gptkb:Schedule_II_(US)
|
|
gptkbp:discoveredBy
|
1930s
|
|
gptkbp:drugClass
|
benzodiazepine
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:form
|
oral solution
injectable solution
|
|
gptkbp:genericName
|
pentobarbital sodium
|
|
gptkbp:halfLife
|
15-50 hours
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Nembutal
|
|
gptkbp:interactsWith
|
gptkb:beer
gptkb:benzodiazepines
opioids
antihistamines
other CNS depressants
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Abbott_Laboratories
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:notRecommendedFor
|
pregnancy
lactation
children under 8 years
|
|
gptkbp:overdoseSymptoms
|
high
|
|
gptkbp:riskFactor
|
tolerance
dependence
withdrawal symptoms
|
|
gptkbp:routeOfAdministration
|
oral
intramuscular
intravenous
|
|
gptkbp:sideEffect
|
addiction
confusion
drowsiness
respiratory depression
|
|
gptkbp:usedFor
|
sedation
treatment of insomnia
preanesthetic
capital punishment (in some jurisdictions)
emergency treatment of seizures
inducing coma
|
|
gptkbp:usedIn
|
euthanasia
animal anesthesia
|
|
gptkbp:bfsParent
|
gptkb:Pentobarbital
gptkb:pentobarbital
|
|
gptkbp:bfsLayer
|
7
|